CymitQuimica logo

NW-1689

CAS:

Ref. TM-TYD-02772

10mg
To inquire
50mg
To inquire
NW-1689
Targetmol

Product Information

Name:NW-1689
Brand:Targetmol
Description:NW-1689 is a process-related impurity of safinamide mesilate (SAFM), which is a medication used in the treatment of Parkinson's disease (PD). SAFM acts as a highly selective and reversible inhibitor of monoamine oxidase-B (MAO-B) and also blocks sodium and N-type calcium channels. These actions assist in reducing dopamine breakdown and suppressing glutamate release. NW-1689 shares structural similarities with SAFM and exhibits comparable pharmacological effects, making it applicable in Parkinson's disease research.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:246.23
Formula:C14H11FO3
Color/Form:Solid

Technical inquiry about: NW-1689

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.